Articles Referencing RGLS

Renaissance Capital

Active week for IPOs marred by lackluster trading

The fourth quarter got off to an active start this week as six of seven deals on the calendar priced. The trend of pricing pressure continued in October’s first week as four of... Read >>

Wyatt Investment Research

Six More IPOs this Week

The IPO market heated up in September. October is off to an even faster start. Six companies held IPOs this week. While none of them were household names, the sheer quantity speaks to the... Read >>

Renaissance Capital

Regulus Therapeutics prices IPO at $4.00 as expected

Regulus Therapeutics, an early stage biotech developing microRNAs treatments for multiple serious diseases, raised $45 million by offering 11.3 million shares at $4 per share. The company,... Read >>